From: Exclusion of prognostic coronary disease in LV dysfunction using late gadolinium enhancement CMR
 | Performance of LGE CMR (95% Confidence Interval) |
---|---|
Prevalence of prognostic CAD | 47% (38 to 57%) |
Sensitivity | 100% (94 to 100%) |
Specificity | 44% (32 to 58%) |
Positive Predictive Value | 62% (51 to 72%) |
Negative Predictive Value | 100% (87 to 100%) |
False Omission Rate | 0% (0 to 13%) |